Literature DB >> 19908748

Signal enhancement of surface plasmon resonance based immunosensor using gold nanoparticle-antibody complex for beta-amyloid (1-40) detection.

Jin-Ho Lee1, Da-Yeon Kang, Taek Lee, Sang-Uk Kim, Byung-Keun Oh, Jeong-Woo Choil.   

Abstract

Numerous studies have indentified that beta-amyloid (1-40) in cerebrospinal fluid as a potential biomarker for Alzheimer's disease. In order for early detection of the Alzheimer's disease, an ultrasensitive diagnostic tool is required. In this study, an ultrasensitive surface plasmon resonance (SPR) based immunosensor for beta3-amyloid (1-40) was developed and its signal enhanced (1-40) with a gold (Au) nanoparticle-antibody complex. Antibodies to beta3-amyloid (1-40) were immobilized on the Au surface leading to a highly efficient immunoreaction due to the fact the paratope of the antibody faced in the opposite direction to the solid surface. The surface morphology of the bio-surface was investigated by using scanning tunneling microscopy (STM). The binding process of antibody fragments to the Au surface, target analytes, and Au nanoparticle-antibody complexes were monitored using SPR. The plot of SPR angle difference versus beta3-amyloid (1-40) concentration shows a linear correlation over a concentration range of nine orders of magnitude, having a detetion limit up to 1 fg/ml.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19908748     DOI: 10.1166/jnn.2009.1613

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  2 in total

1.  Regenerable and simultaneous surface plasmon resonance detection of aβ(1-40) and aβ(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody.

Authors:  Ning Xia; Lin Liu; Michael G Harrington; Jianxiu Wang; Feimeng Zhou
Journal:  Anal Chem       Date:  2010-11-12       Impact factor: 6.986

Review 2.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.